Mathew Blackman

Work

Analyst Mathew Blackman works at STIFEL and is focused on the Healthcare sector with 186 price targets and ratings documented since 2013 spanning on 15 stocks. Analyst's average stock valuation to be materialised ratio is 64.32% with an average time for price targets to be met of 149.27 days.

Most recent stock forecast was given on DXCM, DexCom, Inc at 07-Oct-2022.

Mathew Blackman best performing recommendations are on DXCM (DEXCOM, INC).
The best stock recommendation documented was for DXCM (DEXCOM, INC) at 10/23/2019. The price target of $47 was fulfilled within 15 days with a profit of $10.38 (28.35%) receiving and performance score of 18.9.

Average potential price target upside

AHCO ATEC CERS DXCM GMED NUVA OFIX SENS SPNE CSII ELGX INGN APEN PODD TNDM
AHCO ATEC CERS DXCM GMED NUVA OFIX SENS SPNE CSII ELGX INGN APEN PODD TNDM